Newsletter

185750 - Chong Kun Dang Pharmaceutical Corp.

185750 Summary
Biopharma
Stock Price & Overview
₩68,000 -200 (-0.29%) Close · Sep 4, 2026 KST
KOSPI | ₩KRW | Close: ₩68,000  ≈ US$49  ·  Market cap ₩0.9tn (≈ $670m)
Why this page exists. Korean issuers file to DART, not the SEC, and almost nothing is published in English. Titles here are translated; where kstock has read the filing, the row carries the explanation and the amount in won and dollars. How we pick »

185750 DART Filings

DART

Trading plan report by an officer or major shareholder ×2

Filing08/28/26title translated
DART

Half-Year Report

Periodic08/14/26title translated
DART

Preliminary operating results (fair disclosure)

Filing07/31/26title translated
DART

Material matter affecting investment judgment

Filing07/27/26title translated
DART

Fair-trade compliance programme status (notice)

Filing07/22/26title translated
DART

Sustainability report (voluntary)

Filing06/30/26title translated
DART

New Facility Investment

Capex06/11/26title translated
DART

Company Statement on a Rumor or Media Report — “undetermined”

Exchange inquiry06/10/26title translated
DART

Corporate governance report

Filing06/01/26title translated
DART

Quarterly Report

Periodic05/15/26title translated
DART

Material matter affecting investment judgment

Filing05/14/26title translated
7 routine filings (insider holdings reports, IR schedules)DART

5% Ownership Report — Large Holdings

Ownership08/31/26title translated
DART

5% Ownership Report — Short Form

Ownership08/13/26title translated
DART

5% Ownership Report — Large Holdings

Ownership07/16/26title translated
DART

5% Ownership Report — Short Form

Ownership07/01/26title translated
DART

5% Ownership Report — Short Form

Ownership06/26/26title translated
DART

5% Ownership Report — Large Holdings

Ownership06/24/26title translated
DART

5% Ownership Report — Short Form

Ownership06/01/26title translated
18 filings on file, grouped where one event produced many. Source: DART, operated by Korea's Financial Supervisory Service.

Similar to 185750

SymbolLast Price
475830Orum Therapeutics, Inc.₩55,900
+2.6%
195940HK inno.N Corporation₩42,050
+0.7%
003090Daewoong Co., Ltd.₩16,860
-2.0%
086450Dong Kook Pharmaceutical Co., Ltd.₩21,600
-0.9%
115180Qurient Co., Ltd.₩23,050
+17.3%
476830Rznomics, Inc.₩28,200
+6.8%
003850Boryung Corporation₩9,040
+1.6%
950260Ingenia Therapeutics Inc.(reg.s)₩15,580
-1.5%
085660Chabiotech Co., Ltd.₩8,090
+2.1%
476060Onconic Therapeutics, Inc.₩16,440
-3.9%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.